PharmEasy-Backed Aknamed's Net Loss Surges 14X To INR 171 Cr In FY22

Healthcare supply chain startup Aknamed’s net loss widened 13.9X to INR 171.02 Cr in FY22 from INR 12.29 Cr in FY21.

Related Keywords

Mumbai ,Maharashtra ,India ,Saurabh Pandey ,Varun Vohra ,Mahadevan Narayanamoni ,Shaunak Joshi ,Mayank Kapoor , ,